Informazioni sul prodotto
- (2S,3S,4S,5R,6R)-6-[2-(ethoxycarbonylamino)-5-[(2,3,5,6-tetradeuterio-4-fluorophenyl)methylamino]anilino]-3,4,5-trihydroxyoxane-2-carboxylic acid
- Carbamic acid, N-[2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]-, ethyl ester, hydrochloride (1:2)
- Carbamic acid, [2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]-, ethyl ester, dihydrochloride
- D 20443
- Ethyl [2-amino-4-[[(4-fluorophenyl)methyl]amino]phenyl]carbamate Dihydrochloride
- Ethyl {2-Amino-4-[(4-Fluorobenzyl)Amino]Phenyl}Carbamate Dihydrochloride
- Ethyl {2-Amino-4-[(4-Fluorobenzyl)Amino]Phenyl}Carbamate Hydrochloride
- N-(2-Amino-4-(4-fluorobenzylamino)phenyl)carbamic Acid Ethyl Ester Dihydrochloride
- Retigabine 2HCl
Applications Labelled Retigabine N-β-D-Glucuronide, the major metabolite of the antiepileptic drug Retigabine (R189050) that is produced via N-glucuronidation in humans.
References Hiller, A. et al.: Drug Metab. Dispos., 27, 605 (1999); Borlak, J. et al.: Metab. Clin. Exp., 55, 711 (2006); McNeilly, P.P. et al.: Zenobiotica, 27, 431 (1997);
Proprietà chimiche
Richiesta tecnica su: TR-R189062 Retigabine-d4 N-beta-D-Glucuronide
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.